Moderna Stock Jumps on Surprise Q4 Profit, Revenue Beat
• Moderna stock jumped due to better-than-expected Q4 earnings results, including a surprise profit of $0.53 per share vs expected loss of $0.90 per share
• Q4 revenue of $2.8 billion beat expectations thanks to strong international vaccine sales, aided by recognition of deferred revenue
• Bottom line boosted by tax benefit of $147 million
• Future growth prospects from RSV vaccine filing and progress on flu vaccine mRNA-1010
• Motley Fool analyst team did not include Moderna among its top 10 stock picks